STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced plans to release its second quarter fiscal year 2023 financial results on November 7, 2022, at 6:00 am ET. An accompanying conference call will be held at 8:00 am ET the same day for investors and analysts to discuss the results. Participants can access the call via teleconference or live webcast on Haemonetics' investor relations website. A replay of the call will be available for one year starting at 11:00 am ET on November 7, 2022.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.24% News Effect

On the day this news was published, HAE declined 1.24%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Oct. 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2023 financial results at 6:00 am ET on Monday, November 7, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 7, 2022.

The call can be accessed via teleconference at: Q2 2023 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:https://edge.media-server.com/m6/p/qyrbnnof https://edge.media-server.com/mmc/p/jmqoyvd8 

A replay of the conference call and webcast will be available for one year beginning on November 7, 2022 at 11:00 am ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact:
Olga Guyette, Sr. Director, Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com

Media Contact:
Josh Gitelson, Director, Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2023-results-november-7-2022-301643084.html

SOURCE Haemonetics Corporation

FAQ

When does Haemonetics plan to announce Q2 FY 2023 results?

Haemonetics plans to announce Q2 FY 2023 results on November 7, 2022, at 6:00 am ET.

What time will the conference call for Haemonetics' Q2 earnings be held?

The conference call for Haemonetics' Q2 earnings will be held at 8:00 am ET on November 7, 2022.

How can I access the Haemonetics Q2 FY 2023 earnings conference call?

The Haemonetics Q2 FY 2023 earnings conference call can be accessed via teleconference or through a live webcast on their investor relations website.

Will a replay of Haemonetics' Q2 earnings call be available?

Yes, a replay of Haemonetics' Q2 earnings call will be available for one year starting at 11:00 am ET on November 7, 2022.
Haemonetics Corp Mass

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Latest SEC Filings

HAE Stock Data

3.92B
46.23M
1.15%
115.65%
7.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BOSTON